- General Electric, advised by Paul Weiss, agreed to a $21.4 billion sale of its biopharmaceutical unit to Danaher Corporation, whose former CEO, Larry Culp, recently took over as head of GE. The sale of the unit, which provides tools for medical research and the development of advanced therapies, will allow GE to reduce its debt, Culp said. Kirkland & Ellis advised Danaher, according to a report. (BusinessWire.com) (Financial Times) (BN)
- Tesla CEO Elon Musk is back in hot water with the Securities and Exchange Commission over his tweets about the electric car company. On ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.